Achievement Overview
DDI’s Research Output
2024 DDI Publications
27
Reviews, editorials, etc.
32
Collaborative publications
53
Original research publications
112
Total number of publications
Publication History
103
Total number of publications for 2021
93
Total number of publications for 2022
105
Total number of publications for 2023
112
Total number of publications for 2024
Research Projects & Participation
2024 Ongoing Research Projects Per Sector
42
Research Sector Projects
14
Medical Sector Projects
1
DG Directorate Project
Research Participation History
2,007
Total number of participants in 2021
2,051
Total number of participants in 2022
2,013
Total number of participants in 2023
2,396
Total number of participants in 2024
Collaborations
In 2024, DDI continued to expand its national, regional, and international network by strengthening existing partnerships and establishing new collaborations. As shown in the figure below, eleven international partnerships were reviewed and reassessed, while 3 new collaborations were formed.
| BIMDC-Harvard | Onze Lieve Vrede Hospital |
| Cirius Therapeutics* | Oxford University |
| Deakin University | Pfizer* |
| Royal College of Surgeons in Ireland* | University of Ottawa |
| Montreal Diabetes Research Centre | Université Paris Cité INSERM |
| McGill University | University of Texas Health Science Center |
| Sunnybrook Research Institute | Yale University |
Clinical Improvements
2024 Clinical Improvements
60%
T1DM patients achieving HbA1c levels of < 8
>5,900
Patients seen for one-to-one diabetes education
4,439
Investigations provided in the DIC
4,323
Patients were seen across DDI clinics
43,981
Appointments across DDI clinics
400
HCPs trained on retinal & foot screening
*T1DM: Type 1 Diabetes, HCPs: Healthcare professionals
Public Awareness Activities
2024 DDI Activities
94
Activities
115
TV & Radio interviews
53
Press Releases
114
Health awareness videos
214
Public awareness posts
268
Awareness tweets
